This inventor holds 1 USPTO granted patent. Top assignee: Chongqing Academy of Chinese Materia Medica. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dajian Yang: Innovator in Anti-Inflammatory Research
Introduction
Dajian Yang is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic potential. His work focuses on creating innovative solutions to combat inflammation and related health issues.
Latest Patents
Dajian Yang holds a patent for a nicotinic acid derivative A, which exhibits anti-inflammation and anti-platelet aggregation activities. The patent describes a compound with a general structural formula, where R and R are different substitution sites of a main chain, and R' and R' are different substitution sites of a side chain. This nicotinic acid derivative A demonstrates desirable anti-inflammation, anti-tumor, and anti-platelet aggregation activities, showcasing strong selectivity and remarkable clinical application value. He has 1 patent to his name.
Career Highlights
Dajian Yang is affiliated with the Chongqing Academy of Chinese Materia Medica, where he conducts research and development in the field of traditional Chinese medicine and its applications in modern healthcare. His work has been instrumental in bridging the gap between traditional practices and contemporary scientific research.
Collaborations
Dajian Yang collaborates with notable colleagues, including Yong Yang and Yanlei Guo, to advance research in medicinal chemistry and explore new therapeutic avenues.
Conclusion
Dajian Yang's innovative work in developing anti-inflammatory compounds highlights his commitment to improving health outcomes through scientific research. His contributions to the field are paving the way for future advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile